Genetics of rheumatoid arthritis contributes to biology and drug discoveryYukinori Okada, René E. M. Toes, Yuta Kochi et al.|Nature|2013Cited by 2.5k
Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis PatientsTheodore Mellors, Viatcheslav R. Akmaev, Johanna B. Withers et al.|Network and Systems Medicine|2020Cited by 42
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyStanley Cohen, Viatcheslav R. Akmaev, Alvin F. Wells et al.|Rheumatology and Therapy|2021Cited by 34